| Deborah Ann Coughlin, ARNP: AP30007936 | |
|
1340 M St Se, Suite A, Auburn, WA 98002-6755 | |
| (253) 735-2777 | |
| (253) 735-4153 |
| Full Name | Deborah Ann Coughlin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1340 M St Se, Auburn, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033399944 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP30007936 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Ann Coughlin, ARNP: AP30007936 1340 M St Se, Suite A, Auburn, WA 98002-6755 Ph: (253) 735-2777 | Deborah Ann Coughlin, ARNP: AP30007936 1340 M St Se, Suite A, Auburn, WA 98002-6755 Ph: (253) 735-2777 |
News Archive
"It is outrageous that, in 2012, when we have everything we need to beat AIDS, we are still fighting prejudice, stigma, and exclusion," UNAIDS Executive Director Michel Sidibe writes on the Human Rights and HIV/AIDS "Now More Than Ever" blog, adding, "It is my daily reminder that the AIDS response is not just about an epidemic; the AIDS response is, has been, and must be, an instrument to fight for social justice."
SeraCare Life Sciences, Inc. today announced that the Company has launched a set of new products in its diagnostic controls and panels portfolio—the SeraCare HIV-1 Seroconversion Panels. Each of the six panels consists of a set of undiluted plasma samples from a single plasma donor collected over a period of time during the development of detectable specific antibodies to HIV in the blood, or seroconversion, and is highly characterized with enhanced product information.
A recent study published in Muscle & Nerve created by the Centers for Disease Control and Prevention/Food and Drug Administration examined the prevalence of Miller-Fisher syndrome (MFS) occurring after vaccination in the United States.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
› Verified 3 days ago
Mrs. Alicia Austria Paraiso, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20 Auburn Ave, Auburn, WA 98002 Phone: 206-205-6855 Fax: 206-296-8403 | |
Mrs. Oanh Thi Lam, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 31510 120th Ct Se, Auburn, WA 98092 Phone: 315-399-7573 | |
Ms. Lucie Mckee, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 E Main St, Suite 100, Auburn, WA 98002 Phone: 253-939-9654 Fax: 253-939-6549 | |
Linda Josephine Matthews, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 29224 120th Way Se, Auburn, WA 98092 Phone: 206-249-5440 | |
Ms. Jennifer Christine Drake, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4240 Auburn Way N, Sound Mental Health, Auburn, WA 98002 Phone: 253-876-8900 Fax: 253-876-8910 | |
Dixie Leah Reynolds, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 202 N Division St Ste 202, Auburn, WA 98001 Phone: 253-876-8088 |